Mubalake Abudoureyimu
Overview
Explore the profile of Mubalake Abudoureyimu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
146
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Abudoureyimu M, Sun N, Chen W, Lin X, Pan F, Wang R
Int J Immunopathol Pharmacol
. 2025 Feb;
39:3946320251316692.
PMID: 39895095
Objective: This study aimed to investigate whether the dysregulation of Aurora-A is involved in lenvatinib resistance in hepatocellular carcinoma. Methods: Bioinformatics tools and drug sensitivity assays were used to investigate...
2.
Lin X, Pan F, Abudoureyimu M, Wang T, Hao L, Wang R
Biochem Biophys Res Commun
. 2023 Nov;
690:149247.
PMID: 38000292
Methods: In this study, we used HCC cell lines to investigate whether the combination of the two drugs could enhance their individual strengths and mitigate their weaknesses, thereby providing greater...
3.
Tian C, Abudoureyimu M, Lin X, Chu X, Wang R
Cell Death Dis
. 2021 Dec;
13(1):26.
PMID: 34949761
No abstract available.
4.
Tian C, Abudoureyimu M, Lin X, Chu X, Wang R
Cell Death Dis
. 2021 Nov;
12(11):1047.
PMID: 34741030
Linc-ROR have been well-demonstrated to play important roles in cancer progression and angiogenesis. However, the underlying oncogenic mechanism of Linc-ROR in hepatocellular carcinoma is poorly understood. In this study, we...
5.
Lai Y, Huang H, Abudoureyimu M, Lin X, Tian C, Wang T, et al.
Am J Cancer Res
. 2021 Jan;
10(12):4066-4084.
PMID: 33414986
Reprogramming of metabolism is one of the hallmarks of cancer, among which glucose metabolism dysfunction is the most prominent feature. The glucose metabolism of tumor cells is significantly different from...
6.
Lin X, Xiang X, Hao L, Wang T, Lai Y, Abudoureyimu M, et al.
Am J Cancer Res
. 2020 Oct;
10(9):2705-2729.
PMID: 33042612
Aurora-A is a mitotic serine/threonine-protein kinase and an oncogene. In normal cells, Aurora-A appears from G2 phase and localizes at the centrosome, where it participates in centrosome replication, isolation and...
7.
Zhou H, Feng B, Abudoureyimu M, Lai Y, Lin X, Tian C, et al.
Life Sci
. 2020 Sep;
261:118362.
PMID: 32871184
Background: Non-small cell lung cancer (NSCLC) is the most commonly diagnosed solid cancer and the main origin of cancer-related deaths worldwide. Current strategies to treat advanced NSCLC are based on...
8.
Abudoureyimu M, Lai Y, Tian C, Wang T, Wang R, Chu X
Front Oncol
. 2020 May;
10:701.
PMID: 32432043
[This corrects the article DOI: 10.3389/fonc.2019.01182.].
9.
Lai Y, Feng B, Abudoureyimu M, Zhi Y, Zhou H, Wang T, et al.
Front Oncol
. 2020 Mar;
10:277.
PMID: 32195187
[This corrects the article DOI: 10.3389/fonc.2019.01156.].
10.
Abudoureyimu M, Lai Y, Tian C, Wang T, Wang R, Chu X
Front Oncol
. 2019 Nov;
9:1182.
PMID: 31781493
Hepatocellular carcinoma (HCC) is one of the most frequent cancers worldwide, particularly in China. Despite the development of HCC treatment strategies, the survival rate remains unpleasant. Gene-targeted oncolytic viral therapy...